Biological activities of salvianolic acid B from Salvia miltiorrhiza on type 2 diabetes induced by high-fat diet and streptozotocin

Pharmaceutical Biology

Volumn 53, Issue 7, 2015, Pages 1058-1065

  Huang, Mingqing ^a   Wang, Peijian ^b   Xu, Shuyu ^a   Xu, Wen ^a   Xu, Wei ^a   Chu, Kedan ^a   Lu, Jinjian ^c  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b FIRST AFFILIATED HOSPITAL   (China)

^c University of Macau   (Macao)

Author keywords

Diabetes; Glycogen synthesis; Insulin resistance; Oxidative stress

Indexed keywords

FATTY ACID; GLYCOGEN; MALONALDEHYDE; PLANT MEDICINAL PRODUCT; ROSIGLITAZONE; SALVIANOLIC ACID; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BENZOFURAN DERIVATIVE; GLUCOSE BLOOD LEVEL; HERBACEOUS AGENT; SALVIANOLIC ACID B; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG STRUCTURE; GLUCOSE BLOOD LEVEL; GLYCOGEN SYNTHESIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LOW DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; ADVERSE EFFECTS; ANIMAL; BLOOD; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; ISOLATION AND PURIFICATION; LIPID DIET; METABOLISM; SALVIA MILTIORRHIZA; SPRAGUE DAWLEY RAT;

LAMIACEAE; RATTUS; SALVIA MILTIORRHIZA;

ANIMALS; BENZOFURANS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DRUGS, CHINESE HERBAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; SALVIA MILTIORRHIZA; STREPTOZOCIN;

EID: 84930195047     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2014.959611     Document Type: Article

References (32)

1. Basu A, Newman ED, Bryant AL, et al. (2013). Pomegranate polyphenols lower lipid peroxidation in adults with type 2 diabetes but have no effects in healthy volunteers: A pilot study. J Nutr Metab 2013:Article ID 708381, 7 pages.
2. Chan JY, Lam FC, Leung PC, et al. (2009). Antihyperglycemic and antioxidative effects of a herbal formulation of Radix astragali, Radix codonopsis and Cortex lycii in a mouse model of type 2 diabetes mellitus. Phytother Res 23:658-65.
3. Chen YH, Du GH, Zhang JT. (2000). Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats. Acta Pharmacol Sin 21:463-6.
4. Cheng B, Gong H, Li X, et al. (2013). Salvianolic acid B inhibits the amyloid formation of human islet amyloid polypeptideand protects pancreatic beta-cells against cytotoxicity. Proteins 81: 613-21.
5. Commission CP. (2010). Pharmacopoeia of the People's Republic of China. Beijing, China: Chinese Medical Science and Technology Press.
6. Crespy V, Williamson G. (2004). A review of the health effects of green tea catechins in in vivo animal models. J Nutr 134:3431S-40.
7. Ezhumalai M, Radhiga T, Pugalendi KV. (2014). Antihyperglycemic effect of carvacrol in combination with rosiglitazone in high-fat dietinduced type 2 diabetic C57BL/6J mice. Mol Cell Biochem 385: 23-31.
8. Gao HY, Li GY, Lou MM, et al. (2012). Hepatoprotective effect of matrine salvianolic acid B salt on carbon tetrachloride-induced hepatic fibrosis. J Inflamm (Lond) 9:16-21.
9. Huang MQ, Xie YL, Chen LD, et al. (2012). Antidiabetic effect of the total polyphenolic acids fraction from Salvia miltiorrhiza Bunge in diabetic rats. Phytother Res 26:944-8.
10. Islam MS, Choi H. (2008). Dietary red chilli (Capsicum frutescens L.) is insulinotropic rather than hypoglycemic in type 2 diabetes model of rats. Phytother Res 22:1025-9.
11. Keller AC, Ma J, Kavalier A, et al. (2011). Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro. Phytomedicine 19:32-7.
12. Lei XL, Chiou GC. (1986). Studies on cardiovascular actions of Salvia miltiorrhiza. Am J Chin Med 14:26-32.
13. Li GW, Fan XR, Lillioja S, Bennett PH. (1993). A new index to evaluate insulin sensitivity. Chin J Intern Med 32:656-60.
14. Li WL, Zheng HC, Bukuru J, De KN. (2004). Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 92:1-21.
15. Li Y, Chen M, Xuan H, Hu F. (2012). Effects of encapsulated propolis on blood glycemic control, lipid metabolism, and insulin resistance in type 2 diabetes mellitus rats. Evid Based Complement Alternat Med 2012:Article ID 981896, 8 pages.
16. Liu CS, Chen NH, Zhang JT. (2007). Protection of PC12 cells from hydrogen peroxide-induced cytotoxicity by salvianolic acid B, a new compound isolated from Radix salviae miltiorrhizae. Phytomedicine 14:492-7.
17. Lv BQ, Fan YC, Sun LS. (2006). The influence of salvianolic acid B and tanshinone IIA on the nitric oxide and triglyceride in sera of atherosclerosis rabbits. J Tianjin Univ Tradit Chin Med 25:32-4.
18. Matthews DR, Hosker JP, Rudenski AS, et al. (1985). Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-19.
19. McLachlan KA, Alford FP. (2005). The impact of acute elevation of non-esterified fatty acids on insulin sensitivity and secretion in women with former gestational diabetes. Clin Endocrinol (Oxf) 62: 79-84.
20. Mubarak A, Hodgson JM, Considine MJ, et al. (2013). Supplementation of a high-fat diet with chlorogenic acid is associated with insulin resistance and hepatic lipid accumulation in mice. J Agric Food Chem 61:4371-8.
21. Prabhakar PK, Doble M. (2008). A target based therapeutic approach towards diabetes mellitus using medicinal plants. Curr Diabetes Rev 4:291-308.
22. Roden M, Bernroider E. (2003). Hepatic glucose metabolism in humans-Its role in health and disease. Best Pract Res Clin Endocrinol Metab 17:365-83.
23. Rutledge JC, Ng KF, Aung HH, Wilson DW. (2010). Role of triglyceride-rich lipoproteins in diabetic nephropathy. Nat Rev Nephrol 6:361-70.
24. Schalin-Jantti C, Harkonen M, Groop LC. (1992). Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 41:598-604.
25. Shaw JE, Sicree RA, Zimmet PZ. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030.Diabetes Res Clin Pract 87: 4-14.
26. Srinivasan K, Viswanad B, Asrat L, et al. (2005). Combination of highfat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacol Res 52:313-20.
27. Tahrani AA, Piya MK, Kennedy A, Barnett AH. (2010). Glycaemic control in type 2 diabetes: Targets and new therapies. Pharmacol Ther 125:328-61.
28. Xie W, Du L. (2011). Diabetes is an inflammatory disease: Evidence from traditional Chinese medicines. Diabetes Obes Metab 13: 289-301.
29. Yang W, Lu J, Weng J, et al. (2010). Prevalence of diabetes among men and women in China. N Engl J Med 362:1090-101.
30. Zheng F, Guo MJ, Gu LY, Fan YC. (2011). Effects of salvianolic acid B on stability of atherosclerotic plaque in apolipoprotein E gene knockout mice treated with STZ and high fat diet. Chin J Arterioscler 11: 89-93.
31. Zhou CJ, Huang MQ, Chen CQ, et al. (2012). Salvianolic acids improves glucose and lipid metabolism and insulin resistance in rat models with type 2 diabetes. Chin J Exp Tradit Med Formulae 18: 233-7.
32. Zhou L, Zuo Z, Chow MS. (2005). Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45:1345-59.